What Grade 4 knee cartilage damage actually means

A scan report describing Grade 4 cartilage damage can feel alarming — and it does represent the most severe tier on the ICRS (International Cartilage Repair Society) grading scale. In plain terms, Grade 4 means the cartilage has been lost all the way down to, and through, the underlying subchondral bone. The bony foundation of the joint surface is exposed rather than merely worn thin.

This distinguishes Grade 4 from Grade 3, where more than half the cartilage depth is destroyed but some protective tissue still remains above the bone. Once that final layer is gone, the structural base of the joint surface is compromised — and that is what makes repair both more urgent and more technically demanding.

The distinction between a focal Grade 4 defect — confined to a defined patch, often following trauma or a failed earlier procedure — and diffuse Grade 4 involvement across a compartment or the whole joint is the single most important factor in deciding what to do next. The two scenarios call for entirely different conversations.

It is also worth noting that MRI findings and symptoms do not always align. Some patients with full-thickness damage remain functionally active; others with smaller lesions are significantly limited. A scan finding alone does not determine the pathway — clinical assessment of the whole knee, including alignment, stability, and loading pattern, is needed before any decision is made.

How defect size, age and treatment history shape the decision

Three variables shape almost every Grade 4 cartilage decision before a specific technique is even considered: how large the defect is, how old the patient is, and what has already been done to the knee.

Defect size is the primary triage variable. Lesions under roughly 2–4 cm² respond to a wider range of repair options and tend to produce more predictable results. Above that threshold the biological demands shift considerably — larger Grade 4 defects consistently show better long-term outcomes with cell-based repair or osteochondral allograft than with marrow stimulation. A network meta-analysis of 21 RCTs in 891 patients placed marrow stimulation last among available surgical repair techniques at 10-year follow-up; cell-based techniques show markedly better outcomes for defects above approximately 3 cm², as the evidence in the following section details.

Age and activity level are consistent outcome modifiers. In a cohort of 113 patients followed after knee cartilage restoration, younger age independently predicted achieving both the minimal clinically important difference and the patient-acceptable symptom state across all outcomes measured. The evidence for aggressive biological repair is strongest in younger, active individuals; that does not exclude older patients but does influence the risk-benefit calculation.

Treatment history matters more than is often assumed. A previous microfracture procedure is not neutral background: the technique penetrates the subchondral bone plate, and that structural disruption is cumulative. Prior marrow stimulation can compromise the bony foundation that cell-based and allograft repairs depend on, narrowing what remains technically viable.

Body weight, smoking status, and knee alignment complete the pre-operative picture. Higher BMI and nicotine use are established graft-failure risk factors. Varus alignment — where load is concentrated through the medial compartment — means a cartilage repair performed without correcting the mechanical axis is working against structural forces from day one.

These factors together place each patient somewhere on a spectrum: from targeted biological restoration at one end, through joint-preserving alignment correction, to whole-joint replacement at the other — and which is realistic depends on all four variables in combination.

Cartilage restoration techniques for Grade 4 defects

Biological repair for Grade 4 defects spans four main approaches, each suited to a different part of the size and complexity range.

Microfracture — a baseline, not a modern first choice

Microfracture punctures the subchondral bone to release marrow cells that form a repair tissue — but that tissue is fibrocartilage, not the native hyaline cartilage it replaces. A network meta-analysis of 21 randomised controlled trials covering 891 patients ranked microfracture last among all surgical repair options; at 10-year follow-up, failure rates were significantly higher than with cell-based techniques. Clinical results typically begin to deteriorate after two to three years, and — as covered in the previous section — the bone-plate disruption limits what can be done if a further procedure is needed. Microfracture remains in the literature as the comparison standard against which newer methods are tested, not as the preferred treatment for Grade 4 damage.

AMIC and OATS — options at the smaller end

Autologous matrix-induced chondrogenesis (AMIC) augments marrow stimulation with a collagen scaffold, aiming to improve the quality of the repair tissue in a single operative stage. It is a practical middle ground where a two-stage cell-based procedure is not suitable.

Osteochondral autograft transfer (OATS or mosaicplasty) transplants small cylindrical plugs of healthy bone-and-cartilage from a lower-load area of the same knee. The technique is well-suited to lesions in the 1–4 cm² range and carries solid 10-year data, though donor-site morbidity at the harvest site is a genuine consideration that warrants discussion before surgery.

MACI — the strongest evidence for mid-to-large defects

Matrix-induced autologous chondrocyte implantation (MACI) is a two-stage, FDA-approved procedure: chondrocytes are harvested arthroscopically, cultured over several weeks, then implanted seeded onto a collagen membrane. The SUMMIT trial — the most cited head-to-head comparison — found significantly better KOOS pain and function scores at both 2 and 5 years for lesions ≥3 cm² treated with MACI versus microfracture. Clinical benefit appears durable to 10 years, even where MRI signal shows some structural change over time. A published case involving a 27-year-old professional footballer with a 9 cm² Grade 4 lateral condyle defect (following two failed microfractures) illustrates what the procedure can achieve: a Tegner-Lysholm score rising from 64 to 91 at two years, with return to competitive football within 12 months — though individual results of this kind should not be taken as typical.

Fresh osteochondral allograft — large defects and salvage

For Grade 4 defects too large for autograft or cell-based repair, and for patients presenting after a failed index procedure, fresh osteochondral allograft (OCA) transplantation transfers donor bone-and-cartilage to reconstruct the articular surface in a single stage. For focal femoral condyle lesions, graft survivorship reaches 82.6% at 5 years and 69.6% at 10 years; in one long-term cohort, 68% of 65 grafts remained in situ and functional at a mean of nearly 13 years. Bipolar lesions — where both femoral and tibial surfaces are involved — carry lower survivorship: 73.8%, 66.6%, and 58.9% at 5, 10, and 15 years respectively. A systematic review of OCA as salvage after failed prior procedures reported a 5-year survival of 79–87.8%, but also a reoperation rate of 42.8%, rising with defect size. Most long-term OCA data come from case series (Level 4 evidence); the Level 1 RCT base that supports MACI does not yet exist for allograft at equivalent follow-up.

When alignment is part of the problem

Surgical planning cannot treat the cartilage in isolation from the alignment that is destroying it. Where Grade 4 damage is concentrated in the medial compartment — the pattern seen most often in varus knees — any repair placed into that compartment will continue to absorb the disproportionate load that caused the original injury. Without addressing the mechanical axis, the graft or restored surface is working against the same structural forces from the first day of rehabilitation.

High tibial osteotomy (HTO) corrects this by taking a wedge of bone from the upper tibia to shift the weight-bearing axis away from the damaged compartment, redirecting load towards the healthier lateral side. It can be performed as a standalone joint-preservation procedure when the cartilage damage is not yet amenable to — or not yet requiring — restoration, or it can be combined with ACI, MACI, or allograft in the same or a staged operation. Combined HTO and cartilage repair is supported for appropriate varus-knee candidates in published systematic review evidence, with outcomes generally superior to cartilage repair performed without alignment correction.

For the less common scenario of valgus-driven lateral compartment damage, distal femoral osteotomy (DFO) performs the equivalent function — correcting a knock-kneed alignment to offload a failing lateral surface.

Both osteotomy strategies sit firmly within the joint-preservation category: they are relevant for patients who are not yet — and with timely intervention may not become — candidates for knee replacement.

When joint replacement becomes the right answer

Biological repair has real limits. For some patients, the clinical picture at presentation — or after one or more failed procedures — means that arthroplasty is not a fallback but the most appropriate first recommendation.

The clearest indication is disease distribution. Grade 4 damage confined to a single compartment with acceptable alignment can still support a restoration conversation; damage that is diffuse across two or three compartments cannot. At that point the joint surface as a whole has deteriorated beyond what any graft, scaffold, or cell-based technique can reconstruct. Similarly, a knee that has already undergone multiple biological repair attempts and continues to cause disabling pain has, in practice, reached the same threshold.

Patient profile matters equally. Older age, higher BMI, and lower physical-activity expectations are consistent predictors of poorer outcomes from cartilage restoration — and are precisely the factors that shift the risk-benefit calculation towards replacement. Nicotine use also independently worsens outcomes from allograft procedures.

For disease confined to one compartment — typically the medial — unicompartmental knee replacement (UKR) replaces only that joint surface, preserving the cruciate ligaments and the unaffected compartments. It is a less extensive procedure than total knee replacement and suits patients where damage remains genuinely localised.

Total knee replacement (TKR) addresses diffuse, multi-compartment Grade 4 disease with well-established survivorship and functional outcome data accumulated over decades. Choosing it at the right time, for the right patient, represents sound clinical judgement — not a concession.

Getting a Grade 4 knee assessment in Lincolnshire

Acting on a Grade 4 diagnosis means getting an assessment that maps the variables that matter: defect size and location, mechanical alignment, and the history of any prior procedures. Those three factors, taken together, determine which part of the spectrum described in this article is relevant for a given patient — and none of them can be inferred from a scan report alone.

Lincolnshire Knee, part of the MSK Doctors group, structures its assessments around exactly this clinical picture. Consultant evaluation is supported by onMRI™ AI-driven MRI analysis, which assists with cartilage segmentation and T2 mapping — useful both for characterising the extent of Grade 4 damage and for monitoring repair tissue over time. Where alignment is a question, MAI Motion® objective gait analysis provides biomechanical data to inform whether an osteotomy component belongs in the plan.

The clinic sees patients at Sleaford (NG34) and Grantham (NG31) without requiring a GP referral. The outcome of an assessment is a management plan shaped by the individual — not a fixed protocol.

To book a consultant assessment, visit lincolnshireknee.co.uk.

1. [1] Cartiform Implantation for focal cartilage defects in the knee: A 2-year clinical and MRI follow-up study. (2021). https://doi.org/10.1016/j.jor.2021.02.025 https://doi.org/10.1016/j.jor.2021.02.025
2. [2] Costal Chondrocyte–Derived Pellet-Type Autologous Chondrocyte Implantation versus Microfracture for Repair of Articular Cartilage Defects: A Prospective Randomized Trial. (2020). https://doi.org/10.1177/1947603520921448 https://doi.org/10.1177/1947603520921448
3. [3] Matrix-induced autologous chondrocyte implantation for a large chondral defect in a professional football player: a case report. (2012). https://doi.org/10.1186/1752-1947-6-173 https://doi.org/10.1186/1752-1947-6-173
4. [4] Autologous chondrocyte implantation. https://en.wikipedia.org/?curid=19074150 https://en.wikipedia.org/?curid=19074150
5. [5] Surgical Techniques for Knee Cartilage Repair: An Updated Large-Scale Systematic Review and Network Meta-analysis of Randomized Controlled Trials. (2020). https://doi.org/10.1016/j.arthro.2019.11.096 https://doi.org/10.1016/j.arthro.2019.11.096
6. [6] Osteochondral Allograft Transplantation as a Salvage Procedure After Failed Index Cartilage Surgery of the Knee: A Systematic Review. (2025). https://doi.org/10.1177/03635465241238466 https://doi.org/10.1177/03635465241238466
7. [7] The Clinically Important Difference and Patient Acceptable Symptomatic State for Commonly Used Patient-Reported Outcomes After Knee Cartilage Repair. (2020). https://doi.org/10.1177/0363546520969883 https://doi.org/10.1177/0363546520969883